These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

975 related articles for article (PubMed ID: 29154964)

  • 1. Lipotoxicity and the gut-liver axis in NASH pathogenesis.
    Marra F; Svegliati-Baroni G
    J Hepatol; 2018 Feb; 68(2):280-295. PubMed ID: 29154964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
    Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
    Farrell GC; Haczeyni F; Chitturi S
    Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myristic acid potentiates palmitic acid-induced lipotoxicity and steatohepatitis associated with lipodystrophy by sustaning de novo ceramide synthesis.
    Martínez L; Torres S; Baulies A; Alarcón-Vila C; Elena M; Fabriàs G; Casas J; Caballeria J; Fernandez-Checa JC; García-Ruiz C
    Oncotarget; 2015 Dec; 6(39):41479-96. PubMed ID: 26539645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
    PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic FTO expression is increased in NASH and its silencing attenuates palmitic acid-induced lipotoxicity.
    Lim A; Zhou J; Sinha RA; Singh BK; Ghosh S; Lim KH; Chow PK; Woon ECY; Yen PM
    Biochem Biophys Res Commun; 2016 Oct; 479(3):476-481. PubMed ID: 27651333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
    Geng Y; Faber KN; de Meijer VE; Blokzijl H; Moshage H
    Hepatol Int; 2021 Feb; 15(1):21-35. PubMed ID: 33548031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Cholesterol in the Pathogenesis of NASH.
    Ioannou GN
    Trends Endocrinol Metab; 2016 Feb; 27(2):84-95. PubMed ID: 26703097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas.
    Kakehashi A; Stefanov VE; Ishii N; Okuno T; Fujii H; Kawai K; Kawada N; Wanibuchi H
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of Nonalcoholic Steatohepatitis.
    Machado MV; Diehl AM
    Gastroenterology; 2016 Jun; 150(8):1769-77. PubMed ID: 26928243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis.
    Bellanti F; Villani R; Facciorusso A; Vendemiale G; Serviddio G
    Free Radic Biol Med; 2017 Oct; 111():173-185. PubMed ID: 28109892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.
    Ibrahim SH; Hirsova P; Gores GJ
    Gut; 2018 May; 67(5):963-972. PubMed ID: 29367207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
    Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
    Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.
    Mota M; Banini BA; Cazanave SC; Sanyal AJ
    Metabolism; 2016 Aug; 65(8):1049-61. PubMed ID: 26997538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
    Yamada S; Kamada N; Amiya T; Nakamoto N; Nakaoka T; Kimura M; Saito Y; Ejima C; Kanai T; Saito H
    BMC Gastroenterol; 2017 Nov; 17(1):136. PubMed ID: 29187142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.